__NOTOC__ Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/S, , was a United States Supreme Court case in which the court held that a generic manufacturer may employ the counterclaim provision of the Drug Price Competition and Patent Term Restoration Act of 1984 to force correction of a use code that inaccurately describes the brand's patent as covering a particular method of using a drug..
References
External links